rs267606750
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The ENST00000300527.9(COL6A2):c.1861G>A(p.Asp621Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D621H) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000300527.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A2 | NM_001849.4 | c.1861G>A | p.Asp621Asn | missense_variant | 25/28 | ENST00000300527.9 | NP_001840.3 | |
COL6A2 | NM_058174.3 | c.1861G>A | p.Asp621Asn | missense_variant | 25/28 | ENST00000397763.6 | NP_478054.2 | |
COL6A2 | NM_058175.3 | c.1861G>A | p.Asp621Asn | missense_variant | 25/28 | NP_478055.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL6A2 | ENST00000300527.9 | c.1861G>A | p.Asp621Asn | missense_variant | 25/28 | 1 | NM_001849.4 | ENSP00000300527 | P1 | |
COL6A2 | ENST00000397763.6 | c.1861G>A | p.Asp621Asn | missense_variant | 25/28 | 5 | NM_058174.3 | ENSP00000380870 | ||
COL6A2 | ENST00000409416.6 | c.1861G>A | p.Asp621Asn | missense_variant | 24/27 | 5 | ENSP00000387115 | |||
COL6A2 | ENST00000413758.1 | c.532G>A | p.Asp178Asn | missense_variant | 10/11 | 3 | ENSP00000395751 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 52
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Mar 05, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 24, 2017 | - - |
Bethlem myopathy 1A Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 04, 2023 | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 621 of the COL6A2 protein (p.Asp621Asn). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant limb-girdle muscular dystrophy and/or Bethlem myopathy (PMID: 11865138, 20576434). It has also been observed to segregate with disease in related individuals. This variant is also known as p.Asp620Asn. ClinVar contains an entry for this variant (Variation ID: 17159). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt COL6A2 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Dec 21, 2023 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Dominant negative and loss of function are known mechanisms of disease in this gene and are associated with Bethlem myopathy 1 (MIM#158810), Ullrich congenital muscular dystrophy 1 (MIM#254090) and Myosclerosis, congenital (MIM#255600). Dominant negative is associated with pathogenic missense variants affecting the Gly-X-Y repeats within the triple helical domain while loss of function is reported for null and missense variants (DECIPHER, PMID: 19884007, 31471117) . (I) 0108 - This gene is associated with both recessive and dominant disease. (OMIM). (I) 0115 - Variants in this gene are known to have variable expressivity. The severity of collagen VI-related dystrophies manifestations may vary among family members who are heterozygous for the same pathogenic variant. (GeneReviews). (I) 0200 - Variant is predicted to result in a missense amino acid change from aspartic acid to asparagine. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools. (SP) 0600 - Variant is located in the annotated von Willebrand factor type A domain (DECIPHER). (I) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. ClinVar contains four pathogenic/likely pathogenic entries, and three families with multiple individuals affected with Bethlem myopathy have been reported in the literature (PMID: 25535305, 32419263). (SP) 0901 - This variant has strong evidence for segregation with disease in two families (PMID: 25535305). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Bethlem myopathy 1B Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 26, 2002 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at